Baltimore-washington Financial Advisors adds VCA Inc (WOOF) to its portfolio

VCA Inc (WOOF) : Baltimore-washington Financial Advisors added new position in VCA Inc during the most recent quarter end. The investment management firm now holds 12,450 shares of VCA Inc which is valued at $874,737 , the company said in a statement filed on Oct 12, 2016 with the SEC.VCA Inc makes up approximately 0.25% of Baltimore-washington Financial Advisors’s portfolio.

Other Hedge Funds, Including , Creative Planning boosted its stake in WOOF in the latest quarter, The investment management firm added 926 additional shares and now holds a total of 3,480 shares of VCA Inc which is valued at $244,505. Fisher Asset Management added WOOF to its portfolio by purchasing 2,921 company shares during the most recent quarter which is valued at $207,858.First Mercantile Trust Co reduced its stake in WOOF by selling 6,711 shares or 35.51% in the most recent quarter. The Hedge Fund company now holds 12,189 shares of WOOF which is valued at $854,571. VCA Inc makes up approx 0.11% of First Mercantile Trust Co’s portfolio.Independent Portfolio Consultants reduced its stake in WOOF by selling 5,230 shares or 34.75% in the most recent quarter. The Hedge Fund company now holds 9,820 shares of WOOF which is valued at $680,821. VCA Inc makes up approx 0.21% of Independent Portfolio Consultants’s portfolio. Washington Trust Bank added WOOF to its portfolio by purchasing 19 company shares during the most recent quarter which is valued at $1,317.

VCA Inc closed down -0.9 points or -1.26% at $70.26 with 5,96,164 shares getting traded on Tuesday. Post opening the session at $70.93, the shares hit an intraday low of $69.95 and an intraday high of $70.99 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, VCA Inc reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.82. The company had revenue of $653.49 million for the quarter, compared to analysts expectations of $637.18 million. The company’s revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS.

Many Wall Street Analysts have commented on VCA Inc. VCA Inc was Resumed by BofA/Merrill to “Buy” on Sep 29, 2016.

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

VCA Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on VCA Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.